Cowealth Medical Holding Co Ltd operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Cowealth Medical Holding Co Ltd with three other
companies in this sector in Taiwan:
Apex Biotechnology Corporation
sales of 1.80 billion Taiwanese Dollars [US$58.37 million]
of which 58%
was Test Strip),
(1.82 billion Taiwanese Dollars [US$59.18 million]
of which 100%
was Manufacturing Medical Equipment & Medica), and
Taidoc Technology Corporation
(3.34 billion Taiwanese Dollars [US$108.74 million]
of which 64%
was Medical Apparatus Manufacturing).
Cowealth Medical Holding Co Ltd reported sales of 3.04 billion Taiwanese Dollars (US$98.73 million)
December of 2017.
increase of 2.4%
versus 2016, when the company's sales were 2.97 billion Taiwanese Dollars.
Despite this increase, sales are still
below the level achieved in 2015, when Cowealth Medical Holding Co Ltd
reported sales of 3.27 billion Taiwanese Dollars.
Sales of Depar. B(Sale Reagent&other) saw an increase
that was more than double the company's growth rate: sales were up
5.3% in 2017, from
2.76 billion Taiwanese Dollars to 2.90 billion Taiwanese Dollars.
Not all segments of Cowealth Medical Holding Co Ltd experienced an increase in sales in 2017:
sales of Depar. A(Sale Equipment) fell 35.6% to 134.15 million Taiwanese Dollars.